Why Pharma Firms Are Upgrading to Modern ERP Systems

Why Pharma Firms Are Upgrading to Modern ERP Systems

Zeenat Parween, Correspondent, India Pharma Outlook

 modern ERP systems

In an industry where anything that goes wrong in terms of compliance could lead to either recalls, regulatory fines, or harm to patients, the pharmaceutical sector is now under grave pressure to adopt modern ERP system.

Pharma transformation is not only about adoption of new technologies but about establishing a resilient, compliant infrastructure that supports everything starting from batch production to international supply lines.

This is why pharmaceutical enterprises are looking to the modern ERP systems in the pharma industry not as optional additions, but as a strategic need. 

Essentially, ERP for the pharma industry integrates the procurement, inventory, manufacturing, quality control and regulatory reporting into a single platform. Furthermore, Pharmaceutical ERP solutions are designed to meet government audit and traceability requirements and control operations through every stage of the product lifecycle as compared to a generic ERP platform. 

Also Read: How Pharma Contract Manufacturing Can Win Big in Weight-Loss Drugs

A lot of enterprises still operate in isolated and fragmented legacy systems, in which data visibility is minimal, and the audit is conducted through manual tracking. Yaveon GmbH has noticed that these systems present obstacles to serialization, audit logging and batch traceability as per GMP. Such circumstances represent regulatory and operational risk, particularly with worldwide regulations such as FDA, EMA, DSCSA, and EU-FMD. 

Driving Operational Agility in Pharma with ERP 

Pharma’s pivot to modern ERP systems is driven by operational urgency and regulatory complexity. George Thompson, Global Director of Life Sciences at PeopleSoft, explained: “It is very important to have flexible software to embrace these new business rules quickly.” 

The ability to be flexible and adapt to changes quickly is no longer an option, but a key. Today the GMP ERP systems automate the expiration management, digital audit trails and batch tracking. When MES, electronic batch records (EBRs), and Quality Management Systems (QMS) are integrated, there is less duplicate data, and fewer chances of increased operational risk. 

Christine Sheehy, VP of Operations at Three Rivers Pharmaceuticals, noted: “It helps us manage the long lead times required for ordering ingredients for our products.” 

Elevating Pharma Operations with Intelligent ERP Solutions 

Cloud ERP for pharma offers companies real-time visibility in the supply chain, which enables them to respond to disruptions in advance and manage them. Dr. Reddy’s Laboratories in India, through Prudhvi Teja, Senior Principal for Digital Operations, emphasized the shift to a "right-first-time" mindset—institutionalizing compliance and operational knowledge via integrated systems. 

In addition to basic modules, it is now possible to achieve predictive analytics, intelligent automation, and AI-based quality controls through modern platforms. This takes the role of ERP to the next level where they are viewed, not as a compliance tool, but as a strategic innovation enabler. ERP validation in regulated industries ensures these systems remain audit-ready while retaining agility.  

Also Read: Indian Pharma Branding Agency Market Outlook, Case Study & More

Existing ERP leaders in the market—SAP S/4HANA, Oracle Cloud ERP, and Microsoft Dynamics 365 have customized their modules to pharma. In the meantime, niche solutions such as Slingshot Pharma and Yaveon provide out-of-the-box compliance, batch traceability and validation for small and midsized manufacturers. 

Greg Liscio, SAP Project Manager at Lannett Company, remarked: “Our competitive edge comes through managing our production cycle time, our supply chain and our inventory.” 

Case studies show companies implementing pharma ERP software achieving 25–30% reductions in inventory discrepancies, faster batch release times, and improved audit response. 

Case Study: ERPNext Implementation for a Mid-Sized Pharma Manufacturer 

One of the midsize pharmaceutical companies with an annual turnover of approximately 400 crore looked to Contetra to deploy ERPNext a cloud-based ERP, designed and developed to support regulated spaces. They aimed to address inefficiency in inventory, delays in compliance documentation, batch production delays and poor departmental coordination.

 

Major challenges included:

  • Stockouts of critical raw materials and overstocking of slow-moving inventory (costing ~Rs 4 crore annually). 
  • Labor-intensive compliance audits under FDA, EMA, CDSCO standards. 
  • Batch release delays averaging 7–10 days. 
  • Lack of real-time and unified reporting across departments. 

Contetra deployed ERPNext in a three-phase rollout: diagnosis and customization, phased implementation with master data migration, and optimization post migration. Enhancements included barcode-based batch traceability, AI-powered inventory forecasts, automated compliance reports, and fully integrated dashboards. 

Within nine months, results included: 

  • 25% increase in production efficiency 
  • 30% faster order fulfillment 
  • 22% reduction in excess inventory and significant stock availability improvement 
  • 70% decrease in compliance preparation time 
  • Rs 10 crore in annual savings from better resource utilization  

This implementation proves the value that ERP system, implemented with discerning customizations and change management practices, can bring transformational results in operational efficiency, automation of compliance requirements, and financial performance. 

ERP as the Catalyst for Pharma’s Digital Future 

The increasing standards of compliance and intensifying pressures in the global marketplace has transformed the concept of ERP implementation in pharma, it is no longer used as a back office upgrade but rather as a strategic facilitator. Platforms that integrate QMS, batch tracking, real-time dashboards and AI ready architecture are set for sustainable growth and flexibility. 

Pharma firms that audit legacy systems, pilot modern ERP systems for pharmaceutical manufacturing, and align digital tools with business goals will not only meet current regulatory and operational demands—they’ll lead the industry in innovation, quality, and operational agility.  

FAQs 

1. What is ERP in the pharmaceutical industry? 

ERP (Enterprise Resource Planning) in pharma refers to software that integrates core business processes—like inventory, manufacturing, quality control, and compliance—into a unified system tailored for pharmaceutical operations. 

2. Is ERP validation required for regulated industries like pharma? 

Yes. Pharma ERP systems must be validated against regulations like FDA 21 CFR Part 11, EU Annex 11, and GMP guidelines to ensure data integrity and reliability. 

3. What ROI can pharma firms expect from ERP systems? 

Typical returns include: 

  • 25–30% reduction in inventory discrepancies 
  • 15–20% improvement in batch release time 
  • Enhanced audit readiness and reduced compliance risk 
  • Overall operational efficiency gains of 20% or more 

on the deck

Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest

Related Articles


© 2025 India Pharma Outlook. All Rights Reserved.